It looks like you're offline.
Open Library logo
additional options menu

MARC Record from Library of Congress

Record ID marc_loc_updates/v39.i46.records.utf8:7676766:2019
Source Library of Congress
Download Link /show-records/marc_loc_updates/v39.i46.records.utf8:7676766:2019?format=raw

LEADER: 02019nam a22003738a 4500
001 2011046246
003 DLC
005 20111109114646.0
008 111107s2012 dcu b 001 0 eng
010 $a 2011046246
020 $a9780844772325 (cloth)
020 $a0844772321 (cloth)
020 $a9780844772332 (paper)
020 $a084477233X (paper)
020 $a9780844772349 (ebook)
020 $a0844772348 (ebook)
035 $a(DNLM)101572510
040 $aDNLM/DLC$cDLC
042 $apcc
060 10 $aQV 773
082 00 $a364.16/68$223
100 1 $aBate, Roger.
245 10 $aPhake :$bthe deadly world of falsified and substandard medicines /$cRoger Bate.
260 $aWashington, D.C. :$bAEI Press,$c2012.
263 $a1203
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 8 $aMachine generated contents note: Preface -- Introduction -- Part I: The Deadly World of Dangerous Medicines -- Historical Examples of Dangerous Medicines -- Understanding the Problem -- Overview of Research Findings and Possible Solutions -- Part II: Dangerous Drug Problems by Location -- Africa -- India -- China -- Middle East -- Other Emerging Markets -- Russia -- Latin America -- Thailand -- Turkey -- The Online Drug Market -- Part III: Drug-Quality Assessments -- Factors to Consider for Research -- Results: What We Found -- Results Broken Out for Africa, India, and Other Markets -- Interpreting the Results -- Part IV: The Way Forward -- Developing Medical Regulatory Authorities: The U.S. FDA as Case Study -- International Cooperation against Criminals and the Lethal Trade in Fake Medicines -- Market for Products of Varying Quality and the Intellectual Property Debate This Book.
520 $a"Drug trade, pharmaceutical industry, counterfeit drugs, product counterfeiting"--Provided by publisher.
650 12 $aCounterfeit Drugs.
650 12 $aFraud.
650 22 $aDrug Industry.
650 22 $aDrug and Narcotic Control.
650 22 $aInternationality.